Letter to the Editor
Not all unsatisfactory ThinPrep® cervical Pap tests™ are unsatisfactory: Reprocessing improves the satisfactory and detection rates of ThinPrep® cervical cytology
Badr AbdullGaffar M.D., F.I.A.C.,
Mohamed O. Kamal B.Sc., C.M.I.A.C.,
Corresponding Author
Badr AbdullGaffar M.D., F.I.A.C.
Histopathology and Cytopathology Department, Dubai Hospital, Dubai, United Arab Emirates
Histopathology Department, Dubai Hospital, P.O. Box 7272, Dubai, United Arab EmiratesSearch for more papers by this authorMohamed O. Kamal B.Sc., C.M.I.A.C.
Histopathology Department, Cytology Unit, Dubai Hospital, Dubai, United Arab Emirates
Search for more papers by this authorBadr AbdullGaffar M.D., F.I.A.C.,
Mohamed O. Kamal B.Sc., C.M.I.A.C.,
Corresponding Author
Badr AbdullGaffar M.D., F.I.A.C.
Histopathology and Cytopathology Department, Dubai Hospital, Dubai, United Arab Emirates
Histopathology Department, Dubai Hospital, P.O. Box 7272, Dubai, United Arab EmiratesSearch for more papers by this authorMohamed O. Kamal B.Sc., C.M.I.A.C.
Histopathology Department, Cytology Unit, Dubai Hospital, Dubai, United Arab Emirates
Search for more papers by this authorNo abstract is available for this article.
References
- 1 Lee KR,Ashfaq R,Birdsong GG, et al. Comparison of conventional Papaniculaou smears and a fluid-based thin-layer system for cervical cancer screening. Obstet Gynecol 1997; 90: 278–284.
- 2 Kurtycz DFI,Hoerl HD. Thin-layer technology: Tempered enthusiasm. Diagn Ctyopathol 2000; 23: 1–5.
- 3 Hutchinson ML,Isenstein LM,Goodman A, et al. Homogenous sampling accounts for the increased diagnostic accuracy using the ThinPrep processor. Am J Clin Pathol 1994; 101: 215–219.
- 4
Solomon D,Nayar R.
The Bethesda System for Reporting Cervical Cytology: Definitions, criteria, and explanatory notes.
2nd ed.
New York:
Springer Verlag;
2004.
10.1007/978-1-4612-2042-8 Google Scholar
- 5 Song LH,Goh EST,Phang LC, et al. Technical aspect of ThinPrep. Singapore Med J 2000; 41: 575–578.
- 6 Pang Y,Smola B,Pu RT, et al. Restoring satisfactory status in ThinPrep test specimens with too few squamous cells and containing microscopic red blood cells. Diagn Cytopathol 2008; 36: 696–700.
- 7 Rowe LR,Bentz JS. A simple method to determine the need for glacial acetic acid treatment of bloody ThinPrep Pap tests before slide processing. Diagn Cytopathol 2004; 31: 321–325.
- 8 Islam S,West AM,Saboorian MH, et al. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions. Cancer 2004; 102: 67–73.
- 9 Bentz J,Rowe LR,Gopez EV, et al. The unsatisfactory ThinPrep Pap test: Missed opportunity for disease detection? Am J Clin Pathol 2002; 117: 457–463.
- 10 Kabbani W,Raisanen J,Thomas S, et al. Cell block findings from residual PreservCyt samples in unsatisfactory ThinPrep Paps: No additional benefit. Diagn Cytopathol 2002; 27: 238–243.
- 11 Massarani-Wafai R,Bakhos R,Wojcik EM, et al. Evaluation of cellular residue in the ThinPrep PreservCyt vial. Diagn Cytopathol 2000; 23: 208–212.
- 12 Haack LA,O'Brien D,Selvaggi SM. Protocol for the processing of bloody cervical specimens: Glacial acetic acid and the ThinPrep® Pap Test™. Diagn Cytopathol 2006; 34: 210–213.
- 13 Feng J,Husain M. Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of bloody ThinPrep specimens with atypical squamous cells of determined significance interpretation: Does pretreatment with acetic e acid affect test performance? Cancer 2005; 105: 452–456.
- 14 Agoff SN,Dean T,Nixon BK, et al. The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: Effect on Hybrid Capture II human papillomavirus testing and clinical follow-up. Am J Clin Pathol 2002; 118: 727–732.
Citing Literature
